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Background. Adverse effects of antidepressants are most common at the beginning of the treatment, but possible also
later. We examined the association between antidepressant use and work-related injuries taking into account the dur-
ation of antidepressant use.
Method. Antidepressant use and work-related injuries between 2000 and 2011 were measured among 66 238 employees
(mean age 43.8 years, 80% female) using linkage to national records (the Finnish Public Sector study). We analysed data
using time-dependent modelling with individuals as their own controls (self-controlled case-series design).
Results. In 2238 individuals who had used antidepressants and had a work-related injury during a mean follow-up of
7.8 years, no increase in the risk of injury was observed in the beginning of antidepressant treatment. However, an
increased injury risk was seen after 3 months of treatment (rate ratio, compared with no recent antidepressant use,
1.27, 95% conﬁdence interval 1.10–1.48). This was also the case among those who had used only selective serotonin re-
uptake inhibitors (n = 714; rate ratio 1.41, 95% conﬁdence interval 1.08–1.83).
Conclusions. Antidepressant use was not associated with an increased risk of work-related injury at the beginning of
treatment. Post-hoc analyses of antidepressant trials are needed to determine whether long-term use of antidepressants
increases the risk of work-related injury.
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Introduction
Antidepressants are currently among the most pre-
scribed drugs worldwide (Reid & Barbui, 2010). In
the USA in 2007–2010, for example, 8% of adults at
18 to 44 years of age and 14% of those at 45 to 64
years of age had used antidepressants in the past 30
days (National Center for Health Statistics, 2013).
However, antidepressants may affect cognition and, re-
cently, it has been suggested that the use of antidepres-
sants might cause unwanted side-effects increasing the
risk of work-related injuries (Palmer et al. 2014).
The evidence on the link between antidepressant use
and work-related injuries is still scarce and inconsist-
ent. In a recent case–control study, the likelihood of
consultation for workplace injury was increased
among individuals using antidepressants (Palmer
et al. 2014). A prospective study found an association
between antidepressant use and risk of unintentional
injury (Tiesman et al. 2006), and in a cross-sectional
study psychotropic drug use was associated with occu-
pational injuries (Bhattacherjee et al. 2003). In contrast,
another cross-sectional study found no association be-
tween psychotropic medication use and work acci-
dents (Wadsworth et al. 2005), and two case–control
studies found little evidence of increased risk of occu-
pational injury in those using any psychotropic drugs
(Gilmore et al. 1996; Pickett et al. 1996).
Importantly, duration of antidepressant use immedi-
ately preceding work-related injury was not assessed
in these studies. This is a major limitation because
many adverse effects of antidepressants are most com-
mon at the beginning of the treatment, but usually
wear off over a couple of weeks or lead to revising
or discontinuing medication (Royal College of
Psychiatrists, 2015). To address this limitation, we con-
ducted a large-scale study to examine the association
between antidepressant use and work-related injuries
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using two separate designs following the analytical ap-
proach of Coupland et al. (2011a, b). In the main ana-
lysis we applied time-dependent modelling using
individuals as their own controls [self-controlled case-
series (SCCS) method]. This method allowed us to de-
termine whether those who had used antidepressants
and had had an injury were likely to have used antide-
pressants speciﬁcally at the time of the injury and what
was their treatment duration; or whether they had
stopped the use shortly before the injury. In sensitivity
analyses, a regular prospective cohort design that
included also non-exposed and non-injured partici-
pants was used.
Method
Study population and design
This study is a part of the Finnish Public Sector study,
which is a cohort study of employees working in 10
towns and six hospital districts (Kivimäki et al. 2010).
The eligible population comprised 99 699 employees
in service and targeted by questionnaire surveys in
2000–2002, 2004 and/or 2008. The Finnish Public
Sector study cohort includes more than a thousand oc-
cupational titles. The most common occupational titles
are childminder, kindergarten assistant, practical
nurse, teacher, nurse, secretary and cleaner (Salo et al.
2012). Participants were linked to employers’ records
and national health registers using unique national
personal identiﬁcation numbers. According to the
Finnish law, written consent is not required for survey
and register-based research, as long as participation is
voluntary; and the participants were informed about
the study aims and the possible record linkages. The
completion of the questionnaire acts as informed con-
sent. The study was approved by the Ethics
Committee of the Hospital District of Helsinki and
Uusimaa.
In all, 78 317 (79%) eligible employees responded at
least once. The ﬁrst response was included for those
who responded to more than one questionnaire. The
prospective cohort, which was used in a sensitivity
analysis, included 66 238 participants and did not sub-
stantially differ from the eligible population in terms of
mean age (43.8 years in the sample, 42.8 years in the
eligible population), the proportion of women (80%
v. 77%) or the proportion of manual workers (16% v.
20%). The date of the survey response was deﬁned as
the date of cohort entry for the prospective cohort.
Our analytical sample for the main analyses
included 2238 participants with at least one antidepres-
sant purchase and work-related injury during the
study period. The date of the beginning of the pre-
exposure time (i.e. 30 days preceding the ﬁrst initiation
of antidepressants), or survey response date if on treat-
ment, was deﬁned as the index date.
Assessment of antidepressant use (exposure)
We extracted information on all purchases of antide-
pressants [Anatomical Therapeutic Chemical (ATC)
code N06A] from the Finnish Prescription Register.
The Finnish Prescription Register is kept by the
Social Insurance Institution and includes records of
all drug purchases reimbursed to Finnish residents in
non-institutional settings. For each dispensed drug,
the record includes the dispensing date, the World
Health Organization (WHO) ATC code (WHO Collab-
orating Centre for Drug Statistics Methodology, 2013),
and the quantity purchased as the number of deﬁned
daily dose (DDD), a proxy for the number of days trea-
ted (WHO Collaborating Centre for Drug Statistics
Methodology, 2013). We extracted information on all
purchases of antidepressants (ATC code N06A) in
our analytic sample, following their index date during
follow-up. All purchases between the index date and
31 December 2011 were included. The time intervals
between days covered by medication and those not
covered were used to determine the exposed and unex-
posed periods for each participant. For this, we ﬁrst
determined the periods covered by antidepressants.
For each period, we used the dispensation date as the
start date and projected the end date using the total
number of DDDs dispensed, and combined consecu-
tive and overlapping periods of medication to form
continuous periods of treatment. A maximum duration
for one dispensation was set to 100 days corresponding
to the maximum of days’ supply that can be reim-
bursed per purchase. To take into account the possibil-
ity that the actual dose was half of the DDD, we
prospectively added to the end date the number of
DDDs of the prescription using 50 DDDs as a max-
imum to ﬁll the gap between prescriptions. This is a
validated method to calculate the number of days a pa-
tient had a medication available during the follow-up
(Lau et al. 1997).
Assessment of work-related injury (outcome)
We obtained records on work-related injuries from the
nationwide register kept by the Federation of Accident
Insurance Institutions. In Finland, all work-related in-
juries are compensated through a statutory employer
insurance system. Compensation for occupational in-
juries takes priority over other forms of statutory com-
pensation and pensions. Commuting injuries are
treated similarly as occupational injuries. We mea-
sured the occurrence of the ﬁrst recorded injury be-
tween the index date and 31 December 2011. In the
Finnish Public Sector study, dislocations, sprains and
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strains (41% of all injuries) are the most frequent types
of injury, upper extremities (36%) is the most common
injury location; and slipping, tripping, stumbling and
falling (25%) is the most common events category
(Kouvonen et al. 2013).
Covariates
Since the method used in our main analysis implicitly
controls for the effects of all measured and unmeas-
ured ﬁxed confounders, covariates were included
only in additional sensitivity analysis in a prospective
cohort design. We measured covariates at the cohort
entry. Age, sex, job contract type and occupational sta-
tus (Virtanen et al. 2011) were derived from employers’
records. Marital status, health-risk behaviours and
health-related variables were obtained from the sur-
veys. We measured smoking, high alcohol consump-
tion (Rimm et al. 1999), insufﬁcient physical activity
(Kujala et al. 1998), body mass index, self-rated health
(Idler & Benyamini, 1997), insomnia symptoms
(Jenkins et al. 1988), usual sleep duration and psycho-
logical distress (Goldberg & Williams, 1988).
Purchases of anxiolytics and sedatives (N05B) and
hypnotics (N05C) were included in further sensitivity
analysis.
Statistical analysis
To reduce the limitations of the cohort design approach
and to address indication bias, we applied the SCCS
method (Whitaker et al. 2006; Coupland et al. 2011a),
and investigated the association between antidepres-
sant use and injuries using only data on those anti-
depressant users who had had a work-related injury
during the follow-up. Because this method is a
within-individuals comparison, the effects of all mea-
sured and unmeasured ﬁxed confounders are implicit-
ly controlled for (Whitaker et al. 2006). This method has
previously been used to examine the relationship be-
tween antidepressant use and a range of adverse out-
comes, including falls, fractures and road trafﬁc
accidents in older adults (Coupland et al. 2011a), and
the relationships between prescription drugs and the
risk of motor vehicle crashes in adults (Gibson et al.
2009). To account for participants stopping and
re-starting treatments, antidepressant use was consid-
ered as a time-varying exposure that could change in
value over the entire follow-up period (Allison, 2010).
From the index date, we determined whether the par-
ticipant was using (exposed to) or not using (unex-
posed to) antidepressants until the end of follow-up.
Since employees cannot experience work-related injury
during sick leave or on the periods they are not
employed, we excluded these periods from our ana-
lysis. This information was extracted from the records
kept by the employers (sick leaves) and the Finnish
Centre for Pensions (employment contracts).
Following the approach applied by Coupland et al.
(2011a, b) we examined the duration of the treatment
as a time-varying exposure based on time between ini-
tiation and discontinuation of antidepressant treat-
ment, categorized as 1–30 days before the ﬁrst
dispensation (pre-exposure period), 1–30 days’ use,
31–90 days’ use, 91 or more days of use; and periods
of 1–30 days, 31–90 days, 91–180 days and >180 days
after stopping treatment. The last category was treated
as the unexposed period (the reference category). We
used a SAS macro for conditional Poisson regression
models (http://statistics.open.ac.uk/sccs) to estimate
rate ratios (RRs) and their 95% conﬁdence intervals
(CIs).
To allow for estimation of the absolute risk of injury
associated with antidepressant use, we conducted a
sensitivity analysis using a regular prospective cohort
design, in which all cohort participants were included.
We determined the periods of use (exposure) and
non-use (non-exposure) of antidepressants for each
participant between the cohort entry and the end of
follow-up. We estimated the associations between
exposure to antidepressants and work-related injuries
with time-dependent Cox proportional hazard models,
adjusting hazard ratios (HRs) (95% CIs) for potential
confounders measured at the cohort entry. Participants
were followed until either the ﬁrst injury, move
abroad, death, or 31 December 2011, whichever came
ﬁrst. For these analyses, we used the SAS program
package, version 9.4 (SAS Institute, Inc.; USA).
Ethical statement
All procedures contributing to this work comply with
the ethical standards of the relevant national and insti-
tutional committees on human experimentation and
with the Helsinki Declaration of 1975, as revised in
2008.
Results
Sociodemographic characteristics of the included parti-
cipants at cohort entry, the number of antidepressant
treatment days per person-year and the number of in-
juries per 100 person-years are presented in Table 1. In
the SCCS analysis cohort, the mean follow-up was 7.8
years between 2000 and 2011. In the total prospective
cohort, the injury risk was 4.3 per 100 person-years
for exposed time and 3.5 per 100 person-years for non-
exposed time.
Table 2 summarizes the results from the SCCS ana-
lysis examining the association between the duration
of antidepressant use and work-related injuries. The
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Table 1. Characteristics of the two cohorts at cohort entry, the Finnish Public Sector Study, 2000–2011
SCCS cohorta Prospective cohortb
Characteristic n (%)
Days of
antidepressant
use/person-year
n of
injuries/100
person-years n (%)
Days of
antidepressant
use/person-year
n of
injuries/100
person-years
Sex
Women 1943 (87) 150.1 15.9 53 195 (80) 21.2 3.5
Men 295 (13) 139.7 16.6 13 043 (20) 15.2 4.1
Age, years
18 to 39 559 (25) 140.2 16.7 22 349 (34) 17.0 3.2
40 to 49 903 (40) 151.8 15.5 22 158 (33) 22.2 3.7
50 to 67 776 (35) 149.8 16.1 21 731 (34) 21.6 3.9
Occupational status
Higher non-manual 476 (21) 151.4 15.7 20 544 (31) 19.4 2.4
Lower non-manual 1291 (58) 149.6 16.0 34 838 (53) 20.9 3.5
Manual 471 (21) 143.6 16.5 10 856 (16) 18.4 6.6
Married or cohabiting
Yes 1486 (66) 146.6 15.7 50 233 (76) 18.2 3.5
No 752 (34) 154.7 16.6 16 005 (24) 26.2 4.0
Type of job contract
Permanent 1854 (83) 151.4 16.0 53 393 (81) 20.9 3.7
Fixed-term 384 (17) 136.0 16.1 12 845 (19) 17.4 3.1
Current smoking
No 1673 (75) 149.1 15.9 54 618 (82) 18.8 3.4
Yes 565 (25) 149.9 16.2 11 620 (18) 26.3 4.3
Heavy drinking
No 2033 (91) 148.4 16.0 60 918 (92) 19.8 3.6
Yes 205 (9) 152.5 16.2 5320 (8) 23.0 3.7
Insufﬁcient physical activity
No 1600 (71) 146.9 15.8 49 886 (75) 18.4 3.5
Yes 638 (29) 153.6 16.5 16 352 (25) 25.4 3.7
Suboptimal self-rated health
No 1366 (61) 143.5 16.0 50 556 (76) 15.3 3.3
Yes 872 (39) 157.1 16.0 15 682 (24) 37.9 4.5
Insomnia symptoms
No or moderate 1445 (65) 147.7 16.1 51 458 (78) 16.1 3.5
Severe 793 (35) 150.7 15.9 14 780 (22) 35.3 4.0
Sleep duration
6.5 h or less 594 (27) 140.6 16.5 14 661 (22) 21.9 4.2
7 to 8.5 h 1548 (69) 149.8 15.8 49 316 (75) 19.0 3.4
9 h or more 96 (4) 181.6 15.9 2261 (3) 33.8 4.0
Psychological distress
No 1335 (60) 145.9 16.5 49 907 (75) 15.7 3.5
Yes 903 (40) 152.8 15.4 16 331 (25) 33.9 4.0
Body mass index, kg/m2
<18.5 28 (1) 141.1 16.7 816 (1) 19.9 3.3
18.5 to 24.9 1147 (51) 142.4 15.5 35 820 (54) 18.0 3.2
25 to 29.9 675 (30) 150.1 16.4 21 325 (32) 21.4 4.0
30+ 388 (17) 167.9 17.0 8247 (13) 27.8 4.6
SCCS, Self-controlled case-series.
a SCCS cohort: participants with at least one antidepressant purchase and injury during the follow-up (n = 2238).
b Prospective cohort: all participants with data on antidepressants, injuries and covariates (n = 66 238).
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results show that compared with stopping treatment
over 6 months ago, only 3 months’ or more of exposure
to antidepressants was associated with a higher risk of
work-related injury (RR = 1.27, 95% CI 1.10–1.48). A
similar association was also observed when those
who had used other psychotropic drugs than antide-
pressants during follow-up were excluded from the
analysis (n = 1021) (RR = 1.27, 95% CI 1.01–1.61) (data
not shown).
Table 3 shows the results from the SCCS analysis
examining the association between the duration of se-
lective serotonin reuptake inhibitor (SSRI) use and
the risk of injury. We excluded those SSRI users who
had used other classes of antidepressants during the
study period. The results were in line with the results
obtained from the analysis including all antidepressant
classes: compared with stopping the treatment over 6
months ago, only 3 months’ or more of exposure to
SSRIs was associated with a higher risk of work-
related injury (RR = 1.41, 95% CI 1.08–1.83).
Table 4 shows the results of the sensitivity analysis
in a regular prospective cohort design. Compared
with non-use, antidepressant use was associated with
an elevated risk of work-related injury (HR = 1.22,
95% CI 1.14–1.30) and this association attenuated
slightly after adjustment for sex, age, marital status, oc-
cupational status, type of job contract, health-risk
behaviours, body mass index, self-rated health, insom-
nia symptoms, sleep duration and psychological dis-
tress (HR = 1.14, 95% CI 1.07–1.22).
Discussion
In this study, no increase in workplace injury risk was
observed at the beginning of antidepressant treatment
and thus our initial hypothesis was refuted. However,
over 3 months’ antidepressant use was associated with
a 27% elevated risk of work-related injury. Similar
results were obtained when the analysis was restricted
to SSRI users. The novelty of our study lies in the time-
dependent design which took into account the dur-
ation of treatment, and the use of the SCCS method.
An advantage of this method is that a person acts as
his/her own control so that confounding factors that
do not vary with time, such as genetics and socio-
economic background, cannot distort the ﬁndings.
The similarities and discrepancies between the
results from the SCCS analyses and those from the sen-
sitivity analyses based on the prospective cohort data
deserve to be discussed. We consider SCCS analyses
as the primary analysis and those based on the cohort
data as secondary analysis because the ﬁrst is less vul-
nerable to confounding that artiﬁcially inﬂates or
attenuates associations. Our cohort analysis adds to
Table 2. Risk of work-related injury by duration of antidepressant
use among participants with at least 1 antidepressant prescription
and injury, conditional Poisson regression (self-controlled case-series
design, n = 2238), the Finnish Public Sector Study, Finland,
2000–2011
Antidepressant
use duration Person-years
Number
of ﬁrst
injuries
Rate ratio
(95% CI)
1–30 days
before use
512 95 1.18 (0.94–1.48)
1–30 days’ use 585 94 1.07 (0.85–1.34)
31–90 days’ use 921 153 1.14 (0.94–1.38)
91 or more days’
use
4195 718 1.27 (1.10–1.48)
Stopped 1–30
days
385 64 1.05 (0.80–1.36)
Stopped 31–90
days
577 100 1.06 (0.85–1.31)
Stopped 91–180
days
671 119 1.06 (0.87–1.29)
Stopped 180+
days
6139 895 1.00 (reference)
CI, Conﬁdence interval.
Table 3. Risk of work-related injury by duration of SSRI use among
participants with at least one SSRI prescription and injury,
conditional Poisson regression (self-controlled case-series design,
n = 714), the Finnish Public Sector Study, Finland, 2000–2011a
SSRI use
duration
Person-
years
Number of
ﬁrst injuries
Rate ratio
(95% CI)
1–30 days before
use
109 23 1.28 (0.81–2.02)
1–30 days’ use 121 16 0.85 (0.50–1.45)
31–90 days’ use 234 36 1.03 (0.71–1.50)
91 or more days’
use
1205 230 1.41 (1.08–1.83)
Stopped 1–30
days
93 17 1.16 (0.70–1.92)
Stopped 31–90
days
150 33 1.38 (0.95–2.00)
Stopped 91–180
days
185 39 1.29 (0.91–1.82)
Stopped 180+
days
2334 320 1.00 (reference)
SSRI, Selective serotonin reuptake inhibitor; CI, conﬁdence
interval.
a Participants with purchases of other classes of antide-
pressants during the study period were excluded.
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the main analysis by allowing the use of a much larger
and less selected population than the SCCS analysis.
The cohort design also enabled us to estimate the abso-
lute risk of injury associated with antidepressant use,
in addition to relative risk. Furthermore, because the
prospective cohort approach is commonly used in pre-
vious studies, its use allows for comparability of
ﬁndings.
The HR of 1.14 (95% CI 1.07–1.22) from the total co-
hort for the comparison between any use and no use of
antidepressants is close to the HR (1.15, 95% CI 1.02–
1.29) obtained from the SCCS analysis when compar-
ing any use (merging periods 1–30 days, 31–90 days
and 91 or more days of use) and no use of antidepres-
sants (merging the periods 30 days prior to antidepres-
sant use, 1–30 days, 31–90 days, 91–180 days and >180
days after stopping treatment). The ﬁnding that the HR
from the SCCS design is slightly higher than the HR
based on the total cohort suggests that the elevated
HR in the total cohort cannot be explained by unmeas-
ured confounding by invariant intrinsic factors.
The basic assumption of the SCCS method is that the
occurrence of an outcome event does not affect the
probability of subsequent exposure (Whitaker et al.
2006); indeed, in a previous study the occurrence of oc-
cupational injury was linked to an increased likelihood
of out-patient treatment for depression (Asfaw &
Souza, 2012). However, as our SCCS analysis design
was extended to the pre-exposure time, we were able
to distinguish the pre-exposure period from the refer-
ence time, thus minimizing any underestimation of
the strength of the association.
Possible mechanisms
Both causal and non-causal mechanisms may explain
the unexpected relationship between long-term anti-
depressant use and increased risk of work-related
injury. First, a long-term causal effect is possible be-
cause most antidepressants are prescribed by starting
at a low dose and, if needed, titrating the dose higher
over the course of weeks to months. As such, if a
pharmacological effect is the mechanism that increases
injury risk the effect may not occur until higher
doses are reached. This is biologically plausible.
Antidepressant use has been associated with increased
risk of falls and fractures (Rizzoli et al. 2012). In a recent
study, SSRIs were shown to increase fracture risk
among middle-aged women without psychiatric disor-
ders (Sheu et al. 2015). In principle, the use of antide-
pressants that act on the serotonin system could
reduce bone mineral density (BMD) and bone loss,
and thus increase fracture risk (Rizzoli et al. 2012;
Vestergaard et al. 2013). With SSRIs, for example, the
increase in risk has been shown to reach a peak within
8 months’ use (Rizzoli et al. 2012). In patients suffering
from bone loss the consequence of the injury may be
more severe leading to sickness absence and thus be-
coming recorded. However, most of the previous evi-
dence on antidepressants, BMD, bone loss and
fracture risk still relates to older adults.
Second, the possibility that the increased injury risk
after 3 months’ antidepressant use may be an artefact
cannot be excluded in non-randomized studies, such
as our investigation. Thus, a possible explanation for
our results and previously observed associations is in-
dication bias, that is, the condition for which the drug
was prescribed rather than the drug itself increasing
the risk (Coupland et al. 2011a). Certain depressive
symptoms such as difﬁculties in concentration, fatigue
and insomnia can lead to an increased risk of injury.
Indeed, depression has been associated with work-
related injuries (Tiesman et al. 2006; Franche et al.
2009; Palmer et al. 2014), decreased BMD and increased
fracture risk (Cizza et al. 2010). Furthermore, antide-
pressants are prescribed for various conditions,
Table 4. Adjusted hazard ratios for work-related injury by antidepressant use in the total cohort (n = 66 238), the Finnish Public Sector Study,
Finland, 2000–2011
Antidepressant use Person-years
Number of
ﬁrst injuries
Model 1a: hazard
ratio (95% CI)
Model 2b: hazard
ratio (95% CI)
Model 3c: hazard
ratio (95% CI)
Any antidepressant use 22 981 977 1.22 (1.14–1.30) 1.21 (1.13–1.29) 1.14 (1.07–1.22)
No antidepressant use 394 780 13 960 1.00 (reference) 1.00 (reference) 1.00 (reference)
CI, Conﬁdence interval.
a Model 1: unadjusted.
bModel 2: adjusted for sex, age, marital status and occupational status.
c Model 3: additionally adjusted for type of job contract, health-risk behaviours (smoking, heavy drinking, insufﬁcient phys-
ical activity), body mass index, self-rated health, insomnia symptoms, sleep duration and psychological distress (General
Health Questionnaire 12).
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although depression is the most common indication
particularly for SSRI use. A recent UK study showed
that in 87% of patients prescribed an SSRI the indica-
tion was depression or mixed depression and anxiety,
and in another 9% it was anxiety disorder (Johnson
et al. 2014). Other classes of antidepressants than
SSRI, such as tricyclic antidepressants, are prescribed
also for indications other than depression (Beck et al.
2005), and symptoms of these diseases may increase
the injury risk (Vingilis & Wilk, 2012). Moreover, anti-
depressant use may be a marker of other pre-existing
conditions, such as musculoskeletal disorders, heart
disease or diabetes, which themselves can increase
the injury risk (Kubo et al. 2014).
To determine whether the observed increased risk is
caused by antidepressants rather than just being an un-
informative marker of other factors, it would be im-
portant that new post-hoc analyses of antidepressant
trials are performed. Increased injury rates after long-
term use (>3 months) of antidepressants in the treat-
ment group compared with the control group would
convincingly demonstrate an adverse off-target effect
of antidepressants which should be taken into account
in clinical practice.
Strengths and limitations
The main strengths of our study are the prospective
use of high-resolution medication data, a record-based
measurement of injury in a large cohort, as well as the
use of study design which took the duration of anti-
depressant use into account. The use of comprehensive
and reliable register data reduces the risk of misclassiﬁ-
cation bias. Prescription data were based on a clinical
assessment by a physician and cover virtually all dis-
pensed out-patient antidepressant prescriptions. We
were able to take into account changes in a person’s ex-
posure status and in sensitivity analysis we excluded
those who had used other types of psychotropic
drugs during the follow-up. We were able to control
for such time-dependent biases as immortal time bias
by removing periods not at risk from the follow-up,
e.g. those due to sickness absence. SCCS implicitly con-
trols for all measured and unmeasured time-invariant
confounders thereby largely removing residual con-
founding and helping to address indication bias
(Whitaker et al. 2006).
At least six limitations warrant discussion. First, we
only had information that the medication had been dis-
pensed from a pharmacy. It is possible that sometimes
medication is purchased but not subsequently taken as
prescribed (Modén et al. 2012). Second, the possibility
of confounding by indication cannot be avoided in
any observational study (Salas et al. 1999). Third, as
antidepressant prescribing and the presence and
severity of depression change over time and are highly
correlated, the analyses cannot separate their effects on
injury that in this study was observed only for over 3
months’ use of antidepressants. However, it is notable
that we did not ﬁnd any associations between shorter
durations of antidepressant treatment and work-
related injury. It seems unlikely that indication or se-
verity biases could have masked the true effect of anti-
depressant use on the workplace injury risk at the
beginning of the treatment. On the contrary, these
biases would have rather led to an overestimation of
the risk.
Fourth, given that the risk of depression following
work-related injury may persist longer than 30 days
(Kim, 2013), it is possible that our pre-exposure win-
dow of 30 days is too narrow. However, the same pre-
exposure window has been used in previous studies
(Coupland et al. 2011b).
Fifth, in our analysis, we removed the periods of
time when employees were on sick leave or not
employed. If the most severely depressed employees
were most likely to be on sick leave after diagnosis
when starting their treatment it is possible that this
leads to an underestimation of the association during
the ﬁrst 3 months of treatment and when the more
severely depressed employees start to return to
work, the injury rate increases. However, this con-
founding by severity of depression and underestima-
tion of risk in the ﬁrst 3 months is an unlikely
explanation for the observations in the present study.
In the SCCS analysis cohort, 13.5% of all person-years
in the ﬁrst month of antidepressant treatment were at-
tributable to sick leaves and therefore excluded from
the analysis; the corresponding proportions were
8.1% in the period more than 90 days of treatment
(when the more severely depressed employees pre-
sumably start to return to work) and 4.8% in the refer-
ence period >180 days after stopping the treatment
(see online Supplementary Table S1). Finally, even
though controlling for ﬁxed factors, SCCS analyses
are still susceptible to confounding from time-varying
factors.
Conclusions
The original hypothesis that adverse effects of antide-
pressants on work-related injury risk, if any, are seen
at the beginning of the treatment when adverse
side-effects are most common was not supported.
However, we found that more than 3 months of anti-
depressant use was associated with a slightly increased
risk of work-related injury. Further studies, preferably
as part of randomized controlled trials, are needed to
determine whether the excess risk is due to adverse
drug effects.
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